Igene Biotechnology Company Top Management

Evaluation of Igene Biotechnology's management performance can provide insight into the firm performance.
Joseph Downs  Insider
Chief Officer
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Igene Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Igene Biotechnology Management Team Effectiveness

The company has return on total asset (ROA) of (0.0821) % which means that it has lost $0.0821 on every $100 spent on assets. This is way below average. Igene Biotechnology's management efficiency ratios could be used to measure how well Igene Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.

Igene Biotechnology Workforce Comparison

Igene Biotechnology is rated second overall in number of employees category among its peers. The total workforce of Materials industry is currently estimated at about 11,573. Igene Biotechnology adds roughly 18.0 in number of employees claiming only tiny portion of all equities under Materials industry.

Igene Biotechnology Benchmark Summation

Operator
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was zero with a total number of output elements of sixty-one. Igene Biotechnology Price Series Summation is a cross summation of Igene Biotechnology price series and its benchmark/peer.

Igene Biotechnology Stakeholder

Joseph DownsChief OfficerProfile

About Igene Biotechnology Management Performance

The success or failure of an entity such as Igene Biotechnology often depends on how effective the management is. Igene Biotechnology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Igene management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Igene management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland. IGENE BIOTECHNOLOGY operates under Agricultural Inputs classification in the United States and is traded on PNK Exchange. It employs 18 people.
Please note, the presentation of Igene Biotechnology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Igene Biotechnology's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Igene Biotechnology's management manipulating its earnings.

Igene Biotechnology Workforce Analysis

Traditionally, organizations such as Igene Biotechnology use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Igene Biotechnology within its industry.

Igene Biotechnology Manpower Efficiency

Return on Igene Biotechnology Manpower

Revenue Per Employee219.9K
Net Loss Per Employee7.8K
Working Capital Per Employee17.3K

Complementary Tools for Igene Pink Sheet analysis

When running Igene Biotechnology's price analysis, check to measure Igene Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Igene Biotechnology is operating at the current time. Most of Igene Biotechnology's value examination focuses on studying past and present price action to predict the probability of Igene Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Igene Biotechnology's price. Additionally, you may evaluate how the addition of Igene Biotechnology to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Transaction History
View history of all your transactions and understand their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories